Newbury Park, CA, United States of America

Rahul Rajan Kaushik

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.3

ph-index = 1


Location History:

  • Thousand Oaks, CA (US) (2022)
  • Newbury Park, CA (US) (2022)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Rahul Rajan Kaushik

Introduction

Rahul Rajan Kaushik is a prominent inventor based in Newbury Park, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations and fusion proteins. With a total of 4 patents to his name, Kaushik continues to push the boundaries of innovation in his field.

Latest Patents

Kaushik's latest patents include groundbreaking work on anti-TNF alpha antibody formulations. These stable adalimumab formulations are designed to improve therapeutic efficacy. Additionally, he has developed VEGFR-Fc fusion protein formulations, which provide methods for creating and utilizing such formulations. Notably, these formulations can be used as ophthalmic solutions, including for intravitreal administration, and may comprise a VEGFR-Fc fusion protein like aflibercept.

Career Highlights

Kaushik is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to collaborate with other talented professionals in the industry, further enhancing his contributions to biotechnology.

Collaborations

Some of his notable coworkers include William Callahan and Alona Teran. Their collaborative efforts have played a crucial role in advancing the research and development of new therapeutic solutions.

Conclusion

Rahul Rajan Kaushik is a distinguished inventor whose work in biotechnology has led to significant advancements in antibody and protein formulations. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…